Is the beta3-adrenergic receptor a new target for treatment of post-infarct ventricular tachyarrhythmias and prevention of sudden cardiac death?

Heart Rhythm. 2008 Feb;5(2):298-9. doi: 10.1016/j.hrthm.2007.10.037. Epub 2007 Nov 1.

Authors

Vadim V Fedorov, Ilya T Lozinsky

PMID: 18242557
DOI: 10.1016/j.hrthm.2007.10.037

No abstract available

Publication types

Comment
Editorial

MeSH terms

Adrenergic beta-3 Receptor Agonists*
Adrenergic beta-Agonists / pharmacology*
Anti-Arrhythmia Agents / pharmacology*
Death, Sudden, Cardiac / prevention & control*
Humans
Myocardial Contraction / drug effects*
Myocardial Infarction / complications*
Risk Factors
Tachycardia, Ventricular / drug therapy*
Tachycardia, Ventricular / etiology
Time Factors

Substances

Adrenergic beta-3 Receptor Agonists
Adrenergic beta-Agonists
Anti-Arrhythmia Agents